Malte Peters - Aug 10, 2021 Form 3 Insider Report for Tango Therapeutics, Inc. (TNGX)

Role
Director
Signature
/s/ Daniella Beckman, as attorney-in-fact
Stock symbol
TNGX
Transactions as of
Aug 10, 2021
Transactions value $
$0
Form type
3
Date filed
8/12/2021, 08:37 PM
Next filing
Jun 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNGX Stock Option (Right to Buy) Aug 10, 2021 Common Stock 119K $1.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in equally quarterly installments over a period of 48 months from September 11, 2018.

Remarks:

Exhibit 24: Power of Attorney